Safety and efficacy of Yupingfeng granules in children with recurrent respiratory tract infection: A randomized clinical trial.

ABSTRACT:

Importance

Recurrent respiratory tract infection (RRTI) is common in children. Inappropriate RRTI treatment will lead to asthma and other diseases, thereby seriously affecting the growth and physical health of children. Immune function modulation can prevent and alleviate childhood RRTI. Yupingfeng (YPF), a patented traditional Chinese medicine (TCM), has immunomodulatory effects and is widely used in China to treat children with RRTI.

Objective

To evaluate the safety and efficacy of YPF monotherapy in treating children with RRTI.

Methods

This multicenter, randomized, double-blind, double-simulation, noninferiority clinical trial was conducted from January 2015 to August 2017, with an 8-week treatment period and 52-week follow-up after the drug withdrawal. Children ag

SUBMITTER: Xu B 

PROVIDER: S-EPMC9218971 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature